论文部分内容阅读
选择冠心病心绞痛312例随机分成3组治疗,以验证苦碟子的疗效。其中甲,乙二组为双盲对照。甲组110例用苦碟子注射液治疗。乙组104例用复方丹参注射液治疗。丙组98例用低分子右旋糖酐注射液治疗。其症状有效率甲、乙、丙三组分别为90.9％、86.5％和89.8％。三组间无显著差异。心电图有效率甲、乙、丙三组分别为51.8％、38.5％和61.2％。甲与乙,丙二组相比均无显著差异(P>0.05)。在苦碟子组治疗中仅1例大便稀溏。作者认为,苦碟子可以作为治疗冠心病心绞痛的有效药物。值得推广应用。
Select 312 cases of coronary heart disease angina pectoris were randomly divided into three groups to verify the efficacy of Kudiezi. Which A, B two groups for the double-blind control. A group of 110 cases with Kudie injection. Group B 104 cases with compound Salvia injection treatment. Group C 98 cases with low molecular weight dextran injection. The symptoms of a, B, C three groups were 90.9%, 86.5% and 89.8%. No significant difference between the three groups. Efficacy of ECG, B, C three groups were 51.8%, 38.5% and 61.2%. A and B, C two groups were no significant difference (P> 0.05). In the Kudzu subgroup, only 1 case of feces was loosely stained. The author believes that kudzu can be used as an effective treatment of angina pectoris. Worth promoting application.